Blog

Visualization in the operating theater is of paramount importance to a successful surgical outcome, and ophthalmology is on the cusp of a new era. Our doctors are finding success with the NGENUITY® 3D Visualization System with DATAFUSIONTM. SightMD’s very own, Dr. Eric Rosenberg has been leading the national transformation in the Cornea, Cataract and Complex… Read More

We are so proud to announce that Dr. Jeffrey Martin is the first surgeon at SightMD to implant the new Alcon Vivity IOL. What is Alcon’s Vivity IOL? Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia.  This non-diffractive lens offers a continuous extended range of vision… Read More

Tired of Glaucoma Eye Drops? Check out Durysta! Do you have Glaucoma? If you’re someone that can’t tolerate the side effects of the topical medications or are having trouble administering your own eye drops, Durysta might be right for you! What is Durysta? Durysta is a new injectable form of Bimatoprost eye drops for glaucoma. … Read More

If you’re experiencing dry eye symptoms like burning, stinging, redness, or overall eye fatigue, you might be suffering from a condition called Meibomian Gland Disorder (MGD). MGD is one of the leading causes of dry eye and occurs when the glands in your eyelids become blocked or damaged, and are unable to produce the outermost… Read More

As a notice to our patients, the staff at all SightMD centers are following new health and safety protocols in response to coronavirus. 1. Upon arrival, all patients will be screened for COVID-19. All patients will have their temperature taken and be screened for COVID-19 by being asked the following questions: Have you tested positive… Read More

An article co-authored by Dr. Alanna Nattis Research has found that adult stem cells can be “moderately effective” in the treatment of advanced keratoconus.  A nonrandomized series showed that intrastromal implantation of autologous adipose-derived adult stem cells, with or without sheets of decellularized donor human corneal stroma, was moderately effective for the treatment of advanced… Read More

We are so proud to announce that Dr. Alanna Nattis was selected to be amongst the 6 surgeons from around the world to discuss new and evolving technologies in refractive surgery for the European Cataract and Refractive Surgery Meeting.  Originally due to be hosted in Amsterdam, the meeting was switched to a virtual platform due… Read More

An article by Dr. Alanna Nattis Advances in the diagnosis and treatment of keratoconus may better help doctors preserve and enhance vision for patients in ways that wasn’t possible before.  Dr. Nattis outlines several techniques and options for keratoconus treatment which have experienced a massive evolution over time.  A combination between early diagnostics and successful… Read More

An article by Dr. Alanna Nattis In an article published in Cataract & Refractive Surgery Today, Dr. Alanna Nattis outlines how to manage dislocated presbyopia-correcting intraocular lenses (PCIOLs).  Dr. Nattis discusses how certain strategies may be chosen for particular patients based on the specific characteristics of each case. “As innovation surrounding cataract and refractive surgery… Read More

In an article written in Cataract & Refractive Surgery Today, Dr. Alanna Nattis and her fellow researchers assessed the bacterial burden on the eyelid margins and within the meibomian glands in 40 patients. After obtaining cultures and performing a variety of diagnostic tests, the researchers found a predominance of coagulase-negative staphylococci within the biofilms of… Read More